BIOL

Biolase, Inc.
BIOL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

35 hedge funds and large institutions have $27.4M invested in Biolase, Inc. in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$41.4K
2
+$27K
3
+$15K
4
TRCT
Tower Research Capital (TRC)
New York
+$15K
5
Northern Trust
Northern Trust
Illinois
+$14.9K

Top Sellers

1
-$44K
2
-$32K
3
-$19K
4
Morgan Stanley
Morgan Stanley
New York
-$15.4K
5
LPL Financial
LPL Financial
California
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$20K
27
$16K
28
$15K
29
$15K
30
$15K
31
$15K
32
$15K
33
$13K
34
$12K
35
$12K
36
$7K
37
$3K
38
$3K
39
$3K
40
$2K
41
$2K
42
$1K
43
$1K
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2